SLEEK

Serial Number 97074876
Registration 7870673
700

Registration Progress

Application Filed
Oct 14, 2021
Under Examination
Apr 4, 2023
Approved for Publication
Feb 7, 2023
Published for Opposition
Feb 7, 2023
Registered
Jul 22, 2025

Trademark Image

SLEEK

Basic Information

Serial Number
97074876
Registration Number
7870673
Filing Date
October 14, 2021
Registration Date
July 22, 2025
Published for Opposition
February 7, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 22, 2025
Registration
Registered
Classes
042

Rights Holder

Editas Medicine, Inc.

03
Address
11 Hurley Street
Cambridge, MA 02141

Ownership History

Editas Medicine, Inc.

Original Applicant
03
Cambridge, MA

Editas Medicine, Inc.

Owner at Publication
03
Cambridge, MA

Editas Medicine, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Sarah Anne Keefe

USPTO Deadlines

Next Deadline
2029 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250722)
Due Date
July 22, 2031
Grace Period Ends
January 22, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

38 events
Date Code Type Description Documents
Jul 22, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jul 22, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 16, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jun 27, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jun 2, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Mar 9, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 3, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 10, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 27, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 27, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Sep 27, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Sep 27, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 3, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 2, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 2, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 2, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 29, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 27, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 27, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 27, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 4, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 7, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 7, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 18, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 3, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 23, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 22, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 22, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 30, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 30, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Nov 30, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 30, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 25, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 25, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 25, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 20, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 11, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 18, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical research and development in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, targeted genomic insertion, targeted genomic integration, genetic diseases, gene therapy and cell therapy; Medical laboratory services in the nature of gene editing for developing cells and protein RNA complexes for medical use
First Use Anywhere: Mar 1, 2022
First Use in Commerce: Mar 1, 2022

Classification

International Classes
042